Suchergebnisse - "Mayer, Karin"

PubPharm (151)

1

Treatment of acute myeloid leukaemia in older patients - scope of intensive therapy? - A retrospective analysis

enthalten in: Hematology (Amsterdam, Netherlands) | 2023

von Mayer, K. | Serries, M. | Hahn-Ast, C. | +3

2

Intensive chemotherapy with or without gemtuzumab ozogamicin in patients with NPM1-mutated acute myeloid leukaemia (AMLSG 09-09) : a randomised, open-label, multicentre, phase 3 trial

enthalten in: The Lancet. Haematology | 2023

von Döhner, H. | Weber, D. | Krzykalla, J. | +72

CommentIn: Lancet Haematol. 2023 Jul;10(7):e478-e479. - PMID 37187197

3

Intensive chemotherapy with or without gemtuzumab ozogamicin in patients with NPM1-mutated acute myeloid leukaemia (AMLSG 09-09) : a randomised, open-label, multicentre, phase 3 trial

enthalten in: The lancet / Haematology | July 2023

von Döhner, H. | Weber, D. | Krzykalla, J. | +34

4

Palbociclib in Acute Leukemias With KMT2A-rearrangement : Results of AMLSG 23-14 Trial

enthalten in: HemaSphere | 2023

von Gaidzik, V. | Paschka, P. | Schlenk, R. | +14

5

Long-Term Efficacy and Safety of Luspatercept for Anemia Treatment in Patients With Lower-Risk Myelodysplastic Syndromes : The Phase II PACE-MDS Study

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2022

von Platzbecker, U. | Götze, K. | Kiewe, P. | +16

6

Midostaurin plus intensive chemotherapy for younger and older patients with AML and FLT3 internal tandem duplications

enthalten in: Blood advances | 2022

von Döhner, H. | Weber, D. | Krzykalla, J. | +29

7

Comparison of Empiric Antibiotic Escalation Therapy with Vancomycin (VAN) versus Linezolid (LIN) in Patients with Febrile Neutropenia

enthalten in: Mediterranean journal of hematology and infectious diseases | 2022

von Mayer, K. | Hegge, N. | Molitor, E. | +2

8

Long-term quality of life of patients with acute promyelocytic leukemia treated with arsenic trioxide vs chemotherapy

enthalten in: Blood advances | 2021

von Efficace, F. | Platzbecker, U. | Breccia, M. | +22

9

Cluster of differentiation 33 single nucleotide polymorphism rs12459419 is a predictive factor in patients with nucleophosmin1-mutated acute myeloid leukemia receiving gemtuzumab ozogamicin

enthalten in: Haematologica | 2021

von Teich, K. | Krzykalla, J. | Kapp-Schwoerer, S. | +16

CommentIn: Haematologica. 2021 Nov 01;106(11):2796-2798. - PMID 34092060

10

Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematologic malignancies and solid tumors : 2020 updated guidelines of the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO/DGHO)

enthalten in: Annals of hematology | 2021

von Classen, A. | Henze, L. | von Lilienfeld-Toal, M. | +13

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[16]